Skip to main content

Amesite Inc.

corporate_fare Company Profile

Amesite Inc.

AMST·NASDAQ·Technology·CIK 0001807166

Amesite Inc. is a technology company that builds and commercializes AI-powered solutions for enterprises and professionals, with a particular focus on the post-acute healthcare market. In fiscal 2026, the company launched a census-based Enterprise tier featuring EMR compatibility, automated interdisciplinary team reporting, and configurable documentation. During the same fiscal year, Amesite introduced the AI-native NurseMagic™ EMR capability and secured its largest enterprise deployment to date, serving an approximately 2,700-patient census. Amesite operates through two product lines: NurseMagic™ and LynkMagic™. NurseMagic™ solutions include a B2B enterprise application and a B2C solution for individual healthcare professionals. LynkMagic™ provides enterprise AI solutions for healthcare and related organizations. The company's products support documentation, workflow, compliance, and oversight, and are designed to improve operational quality and efficiency. The B2C NurseMagic™ app connects directly with working nurses and caregivers, offering tools to reduce documentation time, simplify communication, and support daily workflow. The B2B NurseMagic™ solution serves healthcare businesses, including home health, skilled nursing, hospice, and non-clinical segments. Enterprises adopting NurseMagic™ aim to improve workflow efficiency, data security, and regulatory compliance. Amesite's offerings are engineered for fast, secure deployment and measurable value in demanding business environments.

Amesite Inc. (NASDAQ:AMST) is a publicly traded company in the Technology sector. Wiseek has independently scored 20 items for AMST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-02, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 19 rated 8 or above. Recent SEC coverage for AMST spans PRE 14A, 10-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • Amesite Seeks Approval for 1-for-250 Reverse Split and $25M Discounted Offering
  • Amesite 10-K: Going Concern Warning as Cash Dwindles to $2.4M
  • Shareholders to Vote on Significant Dilution from Warrant Exercises and Equity Plan Increase
  • Shareholders to Vote on Highly Dilutive Equity Plan & Warrant Exercises Critical for Funding
  • Amesite Secures Largest Enterprise Customer for NurseMagic™ Platform, Validating AI Strategy

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
364.78K
Net Income
-3.1M
Diluted EPS
-0.63
Op. Cash Flow
-2.15M
Free Cash Flow
-2.15M
Operating Income
-3.14M
Cash & Equivalents
2.3M
Debt / Equity
0.00×
Net Margin
-8.49×
Shares Outstanding
6.55M sh
Source: 10-K · filed 2026-09-23 · accession 0001213900-26-102676

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 25,472 shares in AMST as of the September 15, 2026 settlement, a 97.2% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 16.4% of AMST volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)25,472 shares as of September 15, 2026
Change vs prior period▲ 97.2%
Days to cover1.00 at avg daily volume of 53,729
Daily short volume (FINRA facilities)16.4% of 23,752 shares on October 2, 2026
5-day average short volume21.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for AMST, detected from its recent SEC filings · based on capital-structure filings through 2026-07-20.

2 recent capital raisesATM program3 shelf registrations

ATM Program Established · Potential Dilution

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$0.96 +0.02% today
52-week range · as of 2026-10-02 $0.77 – $3.9
Market cap
$6.16M
Volume
39.6K (0.3× avg)
3-mo avg 154.6K
Live data · 2026-10-05 02:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AMST - Latest Insights

AMST
Oct 02, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.940
Real-time Price: $0.960 info
Change: +$0.020 (+2%) info
Market Cap: $6.157M info
AMST
Sep 23, 2026, 4:58 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.960 info
Change: -$0.080 (-8%) info
Market Cap: $6.157M info
AMST
Jun 03, 2026, 5:29 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $0.960 info
Change: -$0.350 (-27%) info
Market Cap: $6.157M info
AMST
Jun 03, 2026, 5:29 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $0.960 info
Change: -$0.350 (-27%) info
Market Cap: $6.157M info
AMST
May 19, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $0.960 info
Change: -$1.24 (-56%) info
Market Cap: $6.157M info
AMST
May 19, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $0.960 info
Change: -$0.540 (-36%) info
Market Cap: $6.157M info
AMST
May 18, 2026, 4:51 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.7872
Real-time Price: $0.960 info
Change: +$0.1728 (+22%) info
Market Cap: $6.157M info
AMST
May 18, 2026, 4:46 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7872
Real-time Price: $0.960 info
Change: +$0.1728 (+22%) info
Market Cap: $6.157M info
AMST
May 18, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.7861
Real-time Price: $0.960 info
Change: +$0.1739 (+22%) info
Market Cap: $6.157M info
AMST
May 18, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.7861
Real-time Price: $0.960 info
Change: +$0.1739 (+22%) info
Market Cap: $6.157M info
AMST
May 12, 2026, 5:24 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.8113
Real-time Price: $0.960 info
Change: +$0.1487 (+18%) info
Market Cap: $6.157M info
AMST
Apr 28, 2026, 4:57 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.950
Real-time Price: $0.960 info
Change: +$0.010 (+1%) info
Market Cap: $6.157M info
AMST
Apr 28, 2026, 9:47 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.920
Real-time Price: $0.960 info
Change: +$0.040 (+4%) info
Market Cap: $6.157M info
AMST
Apr 28, 2026, 9:43 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.910
Real-time Price: $0.960 info
Change: +$0.050 (+5%) info
Market Cap: $6.157M info
AMST
Apr 28, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $0.960 info
Change: -$0.2003 (-17%) info
Market Cap: $6.157M info
AMST
Apr 27, 2026, 12:25 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.12
Real-time Price: $0.960 info
Change: -$0.155 (-14%) info
Market Cap: $6.157M info
AMST
Apr 23, 2026, 1:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1.10
Real-time Price: $0.960 info
Change: -$0.140 (-13%) info
Market Cap: $6.157M info
AMST
Apr 20, 2026, 4:00 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $1.76
Real-time Price: $0.960 info
Change: -$0.800 (-45%) info
Market Cap: $6.157M info
AMST
Mar 26, 2026, 10:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.74
Real-time Price: $0.960 info
Change: -$0.780 (-45%) info
Market Cap: $6.157M info
AMST
Feb 05, 2026, 6:46 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.89
Real-time Price: $0.960 info
Change: -$0.9344 (-49%) info
Market Cap: $6.157M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets